| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |